tiprankstipranks
Trending News
More News >
Advertisement

TBG - ETF AI Analysis

Compare

Top Page

TBG

TBG Dividend Focus ETF (TBG)

Rating:68Neutral
Price Target:
TBG Dividend Focus ETF appears to be a solid, income-oriented fund, supported by strong, diversified holdings like Verizon, Merck, Johnson & Johnson, and PepsiCo, which all show healthy financial performance, good cash generation, and generally positive outlooks from recent earnings calls. These strengths are partly offset by holdings such as Chevron, American Electric Power, and Procter & Gamble, where bearish or weaker technical trends, valuation concerns, and some growth or cash flow challenges weigh on the overall picture. The main risk factor is that many top holdings are mature, dividend-focused companies facing issues like high leverage, slower growth, or sector-specific headwinds, which can limit upside in certain market conditions.
Positive Factors
Solid Recent Performance
The ETF has shown steady gains over the past month, three months, and year-to-date, indicating positive recent momentum.
Supportive Top Holdings
Several of the largest positions, including major health care and energy names, have delivered strong year-to-date results that help lift the fund.
Broad Sector Diversification
Holdings are spread across many sectors such as health care, energy, financials, real estate, and consumer defensive, which helps reduce the impact of weakness in any single area.
Negative Factors
High Expense Ratio
The fund’s expense ratio is on the higher side for an ETF, which can eat into long-term returns compared with lower-cost options.
Heavy U.S. Concentration
With the vast majority of assets in U.S. companies and only a small slice in Canada, the ETF offers limited geographic diversification.
Mixed Performance Among Top Holdings
Some key positions, including a major real estate company and a large technology hardware stock, have shown weak year-to-date performance that can drag on overall returns.

TBG vs. SPDR S&P 500 ETF (SPY)

TBG Summary

TBG Dividend Focus ETF is an income-focused fund that invests mainly in U.S. companies known for paying steady, often growing dividends. It doesn’t track a specific index, but follows a high dividend yield theme across many sectors like health care, energy, and real estate. Well-known holdings include Merck, Johnson & Johnson, Chevron, and PepsiCo. Someone might consider TBG if they want regular income plus the chance for long-term growth, while spreading money across many industries. A key risk is that dividend stocks and the ETF’s price can go up and down with the overall stock market.
How much will it cost me?The TBG Dividend Focus ETF has an expense ratio of 0.59%, which means you’ll pay $5.90 per year for every $1,000 invested. This is slightly higher than average because it is actively managed, focusing on selecting high dividend-paying stocks across various sectors to maximize income and growth potential.
What would affect this ETF?The TBG Dividend Focus ETF could benefit from stable economic conditions and low interest rates, which often support dividend-paying companies and sectors like Health Care, Consumer Defensive, and Real Estate. However, rising interest rates or economic downturns might negatively impact dividend yields and sectors such as Financials and Real Estate. Additionally, regulatory changes in the U.S., where the ETF is focused, could influence the performance of top holdings like Simon Property and Chevron.

TBG Top 10 Holdings

TBG’s story is all about steady, dividend-heavy giants doing the heavy lifting. Health care names like Merck and Johnson & Johnson are rising and helping anchor returns, while PepsiCo adds a bit of defensive sparkle with solid, steady gains. On the income side, Chevron and Enterprise Products Partners are contributing, though energy’s mixed tone can occasionally tug performance back. Simon Property and American Electric Power keep the yield engine humming but aren’t big growth drivers. Overall, it’s a U.S.-centric, dividend-first portfolio tilted toward health care, energy, and consumer staples.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
4.87%$10.69M
Chevron4.65%$10.21M$392.73B25.35%
71
Outperform
Merck & Company4.09%$8.98M$285.83B22.25%
80
Outperform
Simon Property3.97%$8.70M$60.71B15.89%
70
Outperform
Verizon3.79%$8.31M$216.70B17.92%
81
Outperform
PepsiCo3.75%$8.23M$218.50B7.60%
78
Outperform
Blackstone Group3.63%$7.96M$130.51B-24.21%
72
Outperform
Procter & Gamble3.54%$7.76M$350.11B-10.31%
69
Neutral
American Electric Power3.30%$7.25M$72.26B26.57%
69
Neutral
Johnson & Johnson3.29%$7.21M$582.04B48.34%
78
Outperform

TBG Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price
Price Trends
50DMA
35.48
Negative
100DMA
34.26
Positive
200DMA
33.30
Positive
Market Momentum
MACD
-0.11
Positive
RSI
38.35
Neutral
STOCH
8.11
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For TBG, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 36.14, equal to the 50-day MA of 35.48, and equal to the 200-day MA of 33.30, indicating a neutral trend. The MACD of -0.11 indicates Positive momentum. The RSI at 38.35 is Neutral, neither overbought nor oversold. The STOCH value of 8.11 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for TBG.

TBG Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$219.41M0.59%
68
Neutral
$608.19M0.50%
72
Outperform
$165.21M0.49%
69
Neutral
$152.58M0.35%
72
Outperform
$70.46M0.35%
71
Outperform
$27.60M0.45%
70
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TBG
TBG Dividend Focus ETF
35.33
3.29
10.27%
FDV
Federated Hermes U.S. Strategic Dividend ETF
ELCV
Eventide High Dividend ETF
HIDV
AB US High Dividend ETF
FDIV
MarketDesk Focused U.S. Dividend ETF
DIVY
Sound Equity Income ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement